Streetbeat News

Products Services

GILD

Kite Pharma, a Gilead Company, has announced the completion of the Marketing Authorization transfer for Yescarta CAR T-cell therapy in Japan from Daiichi Sankyo to Gilead Sciences K.K. The Kite Cell Therapy Business Unit of Gilead Sciences K.K. will now manage the sales and promotion activities of Yescarta in Japan.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:38 pm

WULF

TeraWulf Inc. (NASDAQ:WULF) has achieved 5.5 EH/s and 160 MW of Bitcoin mining capacity, with 91% of its energy coming from zero-carbon sources. The company has near-term expansion potential at its Lake Mariner and Nautilus facilities.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:35 pm

KYMR

Kymera Therapeutics has received FDA Orphan Drug Designation for its MDM2 degrader, KT-253, for the treatment of acute myeloid leukemia.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:35 pm

ROIV

Roivant Sciences reported improved efficacy results from the chronic period of the TUSCANY-2 Phase 2b study of RVT-3101 in ulcerative colitis, leading to higher trading of its shares.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:30 pm

HES

Hess Corporation's CEO announced that oil production from five production vessels in Guyana is expected to exceed design capacity.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:27 pm

BTCUSD

Roger Ver, CEO of Bitcoin.com and early Bitcoin investor, has challenged Elon Musk and Mark Zuckerberg to a cage fight, with the winner choosing the primary cryptocurrency for Twitter, Facebook, and Bitcoin.com. This comes after Musk expressed his willingness to fight Zuckerberg on Twitter.

Portfolio Pulse from Mehab Qureshi

June 22, 2023 | 12:25 pm

SSYS

Peugeot has integrated Stratasys' 3DFashion technology into the interior of its new Inception concept, an electric vehicle featuring 3D printed patterns on velvet. The design is part of Peugeot's vision for future electric vehicles and was made possible using Stratasys J850 TechStyle 3D printers.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:20 pm

PRME

Prime Medicine (NASDAQ: PRME) and Cimeio Therapeutics announced a research collaboration to combine their respective technologies, Prime Editing platform and Shielded Cell and Immunotherapy Pairs (SCIP) platform, to improve hematopoietic stem cell (HSC) transplants for genetic diseases, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS). The collaboration aims to reduce toxicity and expand the utility of HSC transplant and in vivo genetic therapies.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:19 pm

PRME

Prime Medicine and Cimeio Therapeutics have announced a research collaboration to develop prime edited shielded-cell and immunotherapy pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:19 pm

AYRO

Electric vehicle manufacturer AYRO has submitted its new electric vehicle, Vanish, for testing.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:18 pm